Vanda Pharmaceuticals Logo

Vanda Pharmaceuticals

🇺🇸
VNDA
US9216591084

Vanda Pharmaceuticals is a global biopharmaceutical company based in the US, specializing in the development of innovative therapies for rare diseases. Through intensive research, Vanda specifically addresses significant unmet medical needs in the field of neurology.

Next Quarterly Earnings

Wednesday, November 4, 2026
CW 45
After-Hours
In 69 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 7, 2026

Stock Price

Frequently asked questions

When will Vanda Pharmaceuticals report its next quarterly earnings?

Vanda Pharmaceuticals is scheduled to report its next quarterly earnings on 11/04/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Vanda Pharmaceuticals last report quarterly earnings?

Vanda Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -1.04 USD.

How often has Vanda Pharmaceuticals beaten expectations?

Vanda Pharmaceuticals has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Vanda Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.61
Actual:
Q2 2026
Missed
Estimate:-$0.58
Actual:-$1.04
Difference:-$0.46
Q1 2026
Missed
Estimate:-$0.69
Actual:-$0.82
Difference:-$0.13
Price reaction (1 day):-14.1 %
Price reaction (7 days):-13.6 %
Q3 2025
Missed
Estimate:-$1.33
Actual:-$2.39
Difference:-$1.07
Q2 2025
Beat
Estimate:-$0.45
Actual:-$0.38
Difference:+$0.07
Q1 2025
Missed
Estimate:-$0.36
Actual:-$0.46
Difference:-$0.10

Earnings statistics

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-19.7%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Vanda Pharmaceuticals
Ticker Symbol
VNDA
ISIN
US9216591084
Country
🇺🇸
USA
Sector